Estrogen patch shortage impacts hormone replacement therapy access

A shortage of estrogen patches has left many women struggling to access hormone replacement therapy (HRT) for perimenopause and menopause symptoms. The scarcity follows a move by the FDA to remove black box labeling from estrogen-based HRT, which led to increased market demand.

Patients report having to travel long distances, ration medication, or seek supplies in other countries to manage symptoms such as mood swings and physical malaise. Experts suggest the shortage could persist for several months or even years.